Evidence map›Paper›PMID 39956830›Full record

ArticleNature communications2025

Genetic regulation of TERT splicing affects cancer risk by altering cellular longevity and replicative potential.

Oscar Florez-Vargas, Michelle Ho, Maxwell H Hogshead, Brenen W Papenberg, Chia-Han Lee, Kaitlin Forsythe, Kristine Jones, Wen Luo, Kedest Teshome, Cornelis Blauwendraat and 13 more

Erratum issuedAbstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Oscar Florez-VargasLaboratory of Translational Genomics, DCEG, National Cancer Institute, Rockville, MD, USA.ORCID http://orcid.org/0000-0002-4393-2612
Michelle HoLaboratory of Translational Genomics, DCEG, National Cancer Institute, Rockville, MD, USA.ORCID http://orcid.org/0000-0002-9143-2241
Maxwell H HogsheadLaboratory of Translational Genomics, DCEG, National Cancer Institute, Rockville, MD, USA.ORCID http://orcid.org/0000-0002-4976-8067
Brenen W PapenbergLaboratory of Translational Genomics, DCEG, National Cancer Institute, Rockville, MD, USA.ORCID http://orcid.org/0000-0003-3734-3018
Chia-Han LeeLaboratory of Translational Genomics, DCEG, National Cancer Institute, Rockville, MD, USA.
Kaitlin ForsytheLaboratory of Translational Genomics, DCEG, National Cancer Institute, Rockville, MD, USA.ORCID http://orcid.org/0000-0002-1075-0935
Kristine JonesCancer Genomics Research Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.ORCID http://orcid.org/0000-0003-1584-8920
Wen LuoCancer Genomics Research Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Kedest TeshomeCancer Genomics Research Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Cornelis BlauwendraatCenter for Alzheimer's and Related Dementias, National Institute of Aging and National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA.ORCID http://orcid.org/0000-0001-9358-8111
Kimberley J BillingsleyCenter for Alzheimer's and Related Dementias, National Institute of Aging and National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA.
Mikhail KolmogorovCancer Data Science Laboratory, CCR, National Cancer Institute, Bethesda, MD, USA.ORCID http://orcid.org/0000-0002-5489-9045
Melissa MeredithUC Santa Cruz Genomics Institute, Santa Cruz, CA, USA.ORCID http://orcid.org/0000-0001-5736-3193
Benedict PatenUC Santa Cruz Genomics Institute, Santa Cruz, CA, USA.ORCID http://orcid.org/0000-0001-8863-3539
Raj ChariGenome Modification Core, Laboratory Animal Sciences Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.ORCID http://orcid.org/0000-0002-2216-313X
Chi ZhangCancer Genomics Research Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
John S SchneeklothChemical Biology Laboratory, CCR, National Cancer Institute, Frederick, MD, USA.
Mitchell J MachielaIntegrative Tumor Epidemiology Branch, DCEG, National Cancer Institute, Rockville, MD, USA.ORCID http://orcid.org/0000-0001-6538-9705
Stephen J ChanockLaboratory of Genetic Susceptibility, DCEG, National Cancer Institute, Rockville, MD, USA.ORCID http://orcid.org/0000-0002-2324-3393
Shahinaz M GadallaClinical Genetics Branch, DCEG, National Cancer Institute, Rockville, MD, USA.ORCID http://orcid.org/0000-0002-3255-8143
Sharon A SavageClinical Genetics Branch, DCEG, National Cancer Institute, Rockville, MD, USA.ORCID http://orcid.org/0000-0001-6006-0740
Sam M MbulaiteyeInfections and Immunoepidemiology Branch, DCEG, National Cancer Institute, Rockville, MD, USA.ORCID http://orcid.org/0000-0002-8273-9831
Ludmila Prokunina-OlssonLaboratory of Translational Genomics, DCEG, National Cancer Institute, Rockville, MD, USA. prokuninal@mail.nih.gov.ORCID http://orcid.org/0000-0002-9622-2091

Funding

Data Resource for Analyzing Blood &Marrow TransplantsU24CA076518 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI Amy M Moskop, Bronwen Shaw · 1998 to 2026
$105.2M
Long-read DNA sequencing of Alzheimers Disease and Related Dementias casesZIAAG000538 · NIA · NATIONAL INSTITUTE ON AGING · PI COOKSON, MARK · 2020 to 2025
$39.6M
Dockstore: The Community Platform for Reproducible Biomedical Workflows and ApplicationsU24HG011853 · NHGRI · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI Jonathan Lawson, Benedict Paten · 2021 to 2026
$5.7M
NTP INFORMATION SYSTEMS SUPPORT27305C0011 · NIEHS · Z-TECH CORPORATION · 2007 to 2009
$4.3M
Computational tools for uniform processing and integration of human reference atlas data [2 of 5]OT2OD033761 · OD · CARNEGIE-MELLON UNIVERSITY · PI PATEN, BENEDICT, RUFFALO, MATTHEW · 2022 to 2025
$4.2M
PROVIDE RABBITS, RATS, MICE, HAMSTERS, GERBILS, GUINEA PIGS27307C0011 · NIEHS · PI BOLEN, WAYNE · 2007 to 2007
$500k
CCR NIH HHS HHSN261200800001CIntramural NIH HHS ZIA AG000538NCI NIH HHS HHSN261200800001ENCI NIH HHS HHSN261201100007INCI NIH HHS HHSN261201100063CNCI NIH HHS U24 CA076518NHGRI NIH HHS U24 HG011853NHLBI NIH HHS HHSN261201100007CNIEHS NIH HHS 27305C0011NIEHS NIH HHS 27307C0011NIEHS NIH HHS 27398C0011NIH HHS OT2 OD033761Wellcome Trust
6 · The paper itself

Abstract

The chromosome 5p15.33 region, which encodes telomerase reverse transcriptase (TERT), harbors multiple germline variants identified by genome-wide association studies (GWAS) as risk for some cancers but protective for others. Here, we characterize a variable number tandem repeat within TERT intron 6, VNTR6-1 (38-bp repeat unit), and detect a strong link between VNTR6-1 alleles (Short: 24-27 repeats, Long: 40.5-66.5 repeats) and GWAS signals rs2242652 and rs10069690 within TERT intron 4. Bioinformatics analyses reveal that rs10069690-T allele increases intron 4 retention while VNTR6-1-Long allele expands a polymorphic G-quadruplex (G4, 35-113 copies) within intron 6, with both variants contributing to variable TERT expression through alternative splicing and nonsense-mediated decay. In two cell lines, CRISPR/Cas9 deletion of VNTR6-1 increases the ratio of TERT-full-length (FL) to the alternative TERT-β isoform, promoting apoptosis and reducing cell proliferation. In contrast, treatment with G4-stabilizing ligands shifts splicing from TERT-FL to TERT-β isoform, implicating VNTR6-1 as a splicing switch. We associate the functional variants VNTR6-1, rs10069690, and their haplotypes with multi-cancer risk and age-related telomere shortening. By regulating TERT splicing, these variants may contribute to fine-tuning cellular longevity and replicative potential in the context of stress due to tissue-specific endogenous and exogenous exposures, thereby influencing the cancer risk conferred by this locus.

Indexed as

Alternative SplicingNeoplasmsTelomeraseAllelesApoptosisCell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansIntronsMinisatellite RepeatsPolymorphism, Single NucleotideTelomeraseTERT protein, human

Identifiers

PMID39956830
PMCPMC11830802

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.